RPL17 and neoplasm: G3-C12@PLGA not only maintained CXCL9/10 concentrations in tumor tissues for a long time by releasing IFN-γ and continuously recruiting CD8+ T cells into tumors, but also helped anti-PD-1 peptide to function better.